# Annals of Hematology

**Type:** Journals  
**Canonical URL:** https://scholariq.org/journals/annals-of-hematology/

## Facts

| Field | Value |
| --- | --- |
| Open Access | false |
| ISSN-L | 0939-5555 |
| ISSNs | 0939-5555,1432-0584 |
| OpenAlex ID | https://openalex.org/S163204731 |
| Publisher | Springer Science+Business Media |

## Journal papers

- [The IgG Fc receptor family](https://scholariq.org/papers/the-igg-fc-receptor-family/)
- [Vitamin D deficiency and anemia: a cross-sectional study](https://scholariq.org/papers/vitamin-d-deficiency-and-anemia-a-cross-sectional-study/)
- [Erythropoiesis-stimulating agents in the treatment of anemia in myelodysplastic syndromes: a meta-analysis](https://scholariq.org/papers/erythropoiesis-stimulating-agents-in-the-treatment-of-anemia-in-myelodysplastic/)
- [Lactate dehydrogenase-release assay: A reliable, nonradioactive technique for analysis of cytotoxic lymphocyte-mediated lytic activity against blasts from acute myelocytic leukemia](https://scholariq.org/papers/lactate-dehydrogenase-release-assay-a-reliable-nonradioactive-technique-for/)
- [Serum zinc levels in patients with iron deficiency anemia and its association with symptoms of iron deficiency anemia](https://scholariq.org/papers/serum-zinc-levels-in-patients-with-iron-deficiency-anemia-and-its-association/)
- [Detection of the circulating tumor DNAs in angioimmunoblastic T- cell lymphoma](https://scholariq.org/papers/detection-of-the-circulating-tumor-dnas-in-angioimmunoblastic-t-cell-lymphoma/)
- [Real-world comparative effectiveness of triplets containing bortezomib (B), carfilzomib (C), daratumumab (D), or ixazomib (I) in relapsed/refractory multiple myeloma (RRMM) in the US](https://scholariq.org/papers/real-world-comparative-effectiveness-of-triplets-containing-bortezomib-b/)
- [Disease-specific hematopoietic stem cell transplantation in children with inherited bone marrow failure syndromes](https://scholariq.org/papers/disease-specific-hematopoietic-stem-cell-transplantation-in-children-with/)
- [Associations of complementation group, ALDH2 genotype, and clonal abnormalities with hematological outcome in Japanese patients with Fanconi anemia](https://scholariq.org/papers/associations-of-complementation-group-aldh2-genotype-and-clonal-abnormalities/)
- [RE-MIND2: comparative effectiveness of tafasitamab plus lenalidomide versus polatuzumab vedotin/bendamustine/rituximab (pola-BR), CAR-T therapies, and lenalidomide/rituximab (R2) based on real-world data in patients with relapsed/refractory diffuse large B-cell lymphoma](https://scholariq.org/papers/re-mind2-comparative-effectiveness-of-tafasitamab-plus-lenalidomide-versus/)
- [Treatment of pediatric primary hemophagocytic lymphohistiocytosis with the HLH-94/2004 regimens and hematopoietic stem cell transplantation in China](https://scholariq.org/papers/treatment-of-pediatric-primary-hemophagocytic-lymphohistiocytosis-with-the-hlh/)
- [High efficacy of eculizumab treatment for fulminant hemolytic anemia in primary cold agglutinin disease](https://scholariq.org/papers/high-efficacy-of-eculizumab-treatment-for-fulminant-hemolytic-anemia-in-primary/)

---
Source: ScholarIQ — public research metadata, principally OpenAlex. See https://scholariq.org/sources/ for provenance and https://scholariq.org/methodology/ for what these figures mean.